GB201900361D0 - Polypeptide and vaccine - Google Patents
Polypeptide and vaccineInfo
- Publication number
- GB201900361D0 GB201900361D0 GBGB1900361.5A GB201900361A GB201900361D0 GB 201900361 D0 GB201900361 D0 GB 201900361D0 GB 201900361 A GB201900361 A GB 201900361A GB 201900361 D0 GB201900361 D0 GB 201900361D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- vaccine
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1900361.5A GB201900361D0 (en) | 2019-01-10 | 2019-01-10 | Polypeptide and vaccine |
PCT/GB2019/050588 WO2019166830A1 (en) | 2018-03-02 | 2019-03-01 | Epsilon toxin from clostridium perfringens as a vaccine |
EP19716474.2A EP3758744B1 (en) | 2018-03-02 | 2019-03-01 | Epsilon toxin from clostridium perfringens as a vaccine |
US16/976,869 US20200405836A1 (en) | 2018-03-02 | 2019-03-01 | Epsilon toxin from clostridium perfringens as a vaccine |
CN201980016070.7A CN111787943A (en) | 2018-03-02 | 2019-03-01 | Toxins from clostridium perfringens as vaccines |
AU2019227860A AU2019227860A1 (en) | 2018-03-02 | 2019-03-01 | Epsilon toxin from clostridium perfringens as a vaccine |
CA3092804A CA3092804A1 (en) | 2018-03-02 | 2019-03-01 | Epsilon toxin from clostridium perfringens as a vaccine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1900361.5A GB201900361D0 (en) | 2019-01-10 | 2019-01-10 | Polypeptide and vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201900361D0 true GB201900361D0 (en) | 2019-02-27 |
Family
ID=65528111
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1900361.5A Ceased GB201900361D0 (en) | 2018-03-02 | 2019-01-10 | Polypeptide and vaccine |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201900361D0 (en) |
-
2019
- 2019-01-10 GB GBGB1900361.5A patent/GB201900361D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL268593A (en) | Polypeptide variants and uses thereof | |
ZA201708218B (en) | Recombinant yeast and use thereof | |
IL287781A (en) | Clec12a-binding polypeptides and uses thereof | |
IL290414A (en) | Atf5 peptide variants and uses thereof | |
IL287782A (en) | Cd33-binding polypeptides and uses thereof | |
GB201819200D0 (en) | Polypeptide and uses thereof | |
SG11202006669RA (en) | Peptides and uses thereof | |
IL281224A (en) | Peptide vaccines | |
GB202201003D0 (en) | Fusion polypeptide and use thereof | |
EP3816186A4 (en) | Pd-l1-binding polypeptide and use thereof | |
GB202201001D0 (en) | Polypeptide and use thereof | |
IL278830A (en) | Reverse peptide vaccine | |
GB202201004D0 (en) | Reconbinant fusion polypeptide and use thereof | |
SG11202111462VA (en) | Asx-specific protein ligases and uses thereof | |
IL282245A (en) | Vaccine polypeptide compositions and methods | |
EP3611181A4 (en) | Atp1a1-targeting polypeptide and use | |
IL280450A (en) | Cdca1-derived peptide and vaccine containing same | |
IL290643A (en) | Delivery peptides and methods of using the same | |
EP3947418C0 (en) | Peptides and use thereof | |
EP3897691A4 (en) | Il-10-containing vaccines and uses thereof | |
GB201902902D0 (en) | Polypeptide and vaccine | |
GB201900361D0 (en) | Polypeptide and vaccine | |
SG11202007887VA (en) | Cyclic peptides and uses thereof | |
GB201803401D0 (en) | Polypeptide and vaccine | |
GB201803388D0 (en) | Polypeptide and vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |